Skip to main content

Defining the Time-limited Trial for Patients with Critical Illness: An Official American Thoracic Society Workshop Report.

Publication ,  Journal Article
Kruser, JM; Ashana, DC; Courtright, KR; Kross, EK; Neville, TH; Rubin, E; Schenker, Y; Sullivan, DR; Thornton, JD; Viglianti, EM; Costa, DK ...
Published in: Ann Am Thorac Soc
February 2024

In critical care, the specific, structured approach to patient care known as a "time-limited trial" has been promoted in the literature to help patients, surrogate decision makers, and clinicians navigate consequential decisions about life-sustaining therapy in the face of uncertainty. Despite promotion of the time-limited trial approach, a lack of consensus about its definition and essential elements prevents optimal clinical use and rigorous evaluation of its impact. The objectives of this American Thoracic Society Workshop Committee were to establish a consensus definition of a time-limited trial in critical care, identify the essential elements for conducting a time-limited trial, and prioritize directions for future work. We achieved these objectives through a structured search of the literature, a modified Delphi process with 100 interdisciplinary and interprofessional stakeholders, and iterative committee discussions. We conclude that a time-limited trial for patients with critical illness is a collaborative plan among clinicians and a patient and/or their surrogate decision makers to use life-sustaining therapy for a defined duration, after which the patient's response to therapy informs the decision to continue care directed toward recovery, transition to care focused exclusively on comfort, or extend the trial's duration. The plan's 16 essential elements follow four sequential phases: consider, plan, support, and reassess. We acknowledge considerable gaps in evidence about the impact of time-limited trials and highlight a concern that if inadequately implemented, time-limited trials may perpetuate unintended harm. Future work is needed to better implement this defined, specific approach to care in practice through a person-centered equity lens and to evaluate its impact on patients, surrogates, and clinicians.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Ann Am Thorac Soc

DOI

EISSN

2325-6621

Publication Date

February 2024

Volume

21

Issue

2

Start / End Page

187 / 199

Location

United States

Related Subject Headings

  • United States
  • Patients
  • Humans
  • Decision Making
  • Critical Illness
  • Critical Care
  • Consensus
  • 3202 Clinical sciences
  • 3201 Cardiovascular medicine and haematology
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Kruser, J. M., Ashana, D. C., Courtright, K. R., Kross, E. K., Neville, T. H., Rubin, E., … Cox, C. E. (2024). Defining the Time-limited Trial for Patients with Critical Illness: An Official American Thoracic Society Workshop Report. Ann Am Thorac Soc, 21(2), 187–199. https://doi.org/10.1513/AnnalsATS.202310-925ST
Kruser, Jacqueline M., Deepshikha C. Ashana, Katherine R. Courtright, Erin K. Kross, Thanh H. Neville, Eileen Rubin, Yael Schenker, et al. “Defining the Time-limited Trial for Patients with Critical Illness: An Official American Thoracic Society Workshop Report.Ann Am Thorac Soc 21, no. 2 (February 2024): 187–99. https://doi.org/10.1513/AnnalsATS.202310-925ST.
Kruser JM, Ashana DC, Courtright KR, Kross EK, Neville TH, Rubin E, et al. Defining the Time-limited Trial for Patients with Critical Illness: An Official American Thoracic Society Workshop Report. Ann Am Thorac Soc. 2024 Feb;21(2):187–99.
Kruser, Jacqueline M., et al. “Defining the Time-limited Trial for Patients with Critical Illness: An Official American Thoracic Society Workshop Report.Ann Am Thorac Soc, vol. 21, no. 2, Feb. 2024, pp. 187–99. Pubmed, doi:10.1513/AnnalsATS.202310-925ST.
Kruser JM, Ashana DC, Courtright KR, Kross EK, Neville TH, Rubin E, Schenker Y, Sullivan DR, Thornton JD, Viglianti EM, Costa DK, Creutzfeldt CJ, Detsky ME, Engel HJ, Grover N, Hope AA, Katz JN, Kohn R, Miller AG, Nabozny MJ, Nelson JE, Shanawani H, Stevens JP, Turnbull AE, Weiss CH, Wirpsa MJ, Cox CE. Defining the Time-limited Trial for Patients with Critical Illness: An Official American Thoracic Society Workshop Report. Ann Am Thorac Soc. 2024 Feb;21(2):187–199.

Published In

Ann Am Thorac Soc

DOI

EISSN

2325-6621

Publication Date

February 2024

Volume

21

Issue

2

Start / End Page

187 / 199

Location

United States

Related Subject Headings

  • United States
  • Patients
  • Humans
  • Decision Making
  • Critical Illness
  • Critical Care
  • Consensus
  • 3202 Clinical sciences
  • 3201 Cardiovascular medicine and haematology